Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACEVU
ACE Convergence Acquisition
$9.77
-0.1%
$9.77
$9.27
$10.80
N/AN/A2,197 shs800 shs
AMHCU
Amplitude Healthcare Acquisition
$16.28
+7.8%
$16.28
$9.51
$16.28
N/AN/A4,175 shs4,300 shs
ENFAU
890 5th Avenue Partners
$9.01
-13.9%
$9.01
$8.99
$11.05
N/AN/A73,340 shs4,700 shs
10X Capital Venture Acquisition Corp stock logo
VCVCU
10X Capital Venture Acquisition
$11.15
+1.4%
$11.15
$9.94
$19.00
N/AN/A83,573 shs4,300 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACEVU
ACE Convergence Acquisition
0.00%0.00%0.00%0.00%0.00%
AMHCU
Amplitude Healthcare Acquisition
0.00%0.00%0.00%0.00%0.00%
ENFAU
890 5th Avenue Partners
0.00%0.00%0.00%0.00%0.00%
10X Capital Venture Acquisition Corp stock logo
VCVCU
10X Capital Venture Acquisition
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ACEVU
ACE Convergence Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
AMHCU
Amplitude Healthcare Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
ENFAU
890 5th Avenue Partners
N/AN/AN/AN/AN/AN/AN/AN/A
10X Capital Venture Acquisition Corp stock logo
VCVCU
10X Capital Venture Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ACEVU
ACE Convergence Acquisition
0.00
N/AN/AN/A
AMHCU
Amplitude Healthcare Acquisition
0.00
N/AN/AN/A
ENFAU
890 5th Avenue Partners
0.00
N/AN/AN/A
10X Capital Venture Acquisition Corp stock logo
VCVCU
10X Capital Venture Acquisition
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ACEVU
ACE Convergence Acquisition
N/AN/AN/AN/AN/AN/A
AMHCU
Amplitude Healthcare Acquisition
N/AN/AN/AN/AN/AN/A
ENFAU
890 5th Avenue Partners
N/AN/AN/AN/AN/AN/A
10X Capital Venture Acquisition Corp stock logo
VCVCU
10X Capital Venture Acquisition
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ACEVU
ACE Convergence Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
AMHCU
Amplitude Healthcare Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
ENFAU
890 5th Avenue Partners
N/AN/A0.00N/AN/AN/AN/AN/A
10X Capital Venture Acquisition Corp stock logo
VCVCU
10X Capital Venture Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ACEVU
ACE Convergence Acquisition
N/AN/AN/AN/AN/A
AMHCU
Amplitude Healthcare Acquisition
N/AN/AN/AN/AN/A
ENFAU
890 5th Avenue Partners
N/AN/AN/AN/AN/A
10X Capital Venture Acquisition Corp stock logo
VCVCU
10X Capital Venture Acquisition
N/AN/AN/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ACEVU
ACE Convergence Acquisition
3N/AN/ANot Optionable
AMHCU
Amplitude Healthcare Acquisition
20N/AN/ANot Optionable
ENFAU
890 5th Avenue Partners
1,520N/AN/ANot Optionable
10X Capital Venture Acquisition Corp stock logo
VCVCU
10X Capital Venture Acquisition
3N/AN/ANot Optionable

Recent News About These Companies

Cerity Partners to Merge With Venture Capital Advisory Shop
Era Ventures Closes $88M Inaugural Fund
The Silent Venture Capital & Startup Recession
Optum Ventures, BlackRock Innovation invest in Caresyntax

ACE Convergence Acquisition OTCMKTS:ACEVU

$9.77 -0.01 (-0.10%)
As of 11/22/2022

ACE Convergence Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on businesses in the IT infrastructure software and semiconductor sectors. ACE Convergence Acquisition Corp. was incorporated in 2020 and is based in Wilmington, Delaware.

Amplitude Healthcare Acquisition OTCMKTS:AMHCU

$16.28 +1.18 (+7.81%)
As of 09/24/2021

Amplitude Healthcare Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to focus on the life sciences and pharmaceutical services sectors in the United States and Europe. Amplitude Healthcare Acquisition Corporation was incorporated in 2019 and is based in New York, New York.

890 5th Avenue Partners OTCMKTS:ENFAU

$9.01 -1.46 (-13.94%)
As of 12/3/2021

890 Fifth Avenue Partners, Inc. is a principal investment firm that invests in the technology, media, and telecommunications sectors. 890 Fifth Avenue Partners, Inc. was founded in 2020 and is based in New York, New York.

10X Capital Venture Acquisition stock logo

10X Capital Venture Acquisition OTCMKTS:VCVCU

$11.15 +0.15 (+1.36%)
As of 07/22/2021

10X Capital Venture Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on technology and tech-enabled businesses in the United States; and consumer internet, ecommerce, software, healthcare, and financial services industries internationally, as well as other industries that are being disrupted by advances in technology and on technology paradigms. The company was incorporated in 2020 and is based in New York, New York.